Assessment of second-line antiretroviral regimens for HIV therapy in Africa

BACKGROUND: The efficacy and toxic effects of nucleoside reverse-transcriptase inhibitors (NRTIs) are uncertain when these agents are used with a protease inhibitor in second-line therapy for human immunodeficiency virus (HIV) infection in resource-limited settings. Removing the NRTIs or replacing t...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Paton, N, Kityo, C, Walker, A, al., E
التنسيق:	Journal article
اللغة:	English
منشور في:	Massachusetts Medical Society 2014

Assessment of second-line antiretroviral regimens for HIV therapy in Africa. حسب Paton, N, Kityo, C, Hoppe, A, Reid, A, Kambugu, A, Lugemwa, A, van Oosterhout, J, Kiconco, M, Siika, A, Mwebaze, R, Abwola, M, Abongomera, G, Mweemba, A, Alima, H, Atwongyeire, D, Nyirenda, R, Boles, J, Thompson, J, Tumukunde, D, Chidziva, E, Mambule, I, Arribas, JR, Easterbrook, P, Hakim, J, Walker, A, Mugyenyi, P

منشور في 2014

Journal article

Assessment of second-line antiretroviral regimens for HIV therapy in Africa

مواد مشابهة